Polyurethanes as carriers of antitumorous drugs

Polymers for Advanced Technologies

Volumn 9, Issue 4, 1998, Pages 266-270

  Iskakov, Rinat ^a   Batyrbekov, Erkesh ^a   Zhubanov, Bulat ^a   Teleuova, Tynyskul ^b   Volkova, Marina ^b  

^a Institute of Chemical Sciences Academy of Sciences of Kazakhstan   (Kazakhstan)

^b Institute of Eye Diseases ^*  (Kazakhstan)

Author keywords

Cyclophosphane; Drug delivery system; Polyurethane; Thiophosphamide; Vincristine

Indexed keywords

ACTIVATION ENERGY; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; ONCOLOGY; REACTION KINETICS; THERMODYNAMICS;

ANTITUMOROUS DRUGS; CYCLOPHOSPHANE; THIOPHOSPHAMIDE; VINCRISTINE;

POLYURETHANES;

EID: 0032051230     PISSN: 10427147     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1581(199804)9:4<266::AID-PAT752>3.0.CO;2-S     Document Type: Article

References (12)

1. S. Dumitriu Ed., Polymeric Biomatenals, p. 223, Marcel Dekker Inc., New York (1994).
2. Ch. G. Gebelein and Ch. E. Carraher Jr. Eds., Bioactive Polymeric Systems. An Overview, p. 531, Plenum Press, New York, (1985).
3. Sh. W. Shalaby, Y. Ikada, R. Langer and J. Williams Eds., Polymers of Biological and Biomedical Significance, American Chemical Society, Washington, DC (1994).
4. E. Touitou and D. Friedman, Int. J. Pharm., 19, 323 (1984).
5. M. Van Bos and E. Schacht, Acta Pharm. Technol., 33(3), 120 (1987).
6. R. W. Baker, US Patent 4839, 174 (1989).
7. N. Yui, K. Kataoka, A. Yamada and Y. Sakurai, J. Contr. Rel., 6, 329 (1987).
8. B. Chaudhuri et al., Int. J. Pharm., 42, 117 (1988).
9. H. E. Stagg, Analyst, 71, 551 (1946).
10. E. Batyrbekov, S. A. Moshkevich, L. B. Rukhina, R. Bogin and B. A. Zhubanov, Br. Polym. J., 23, 273 (1990).
11. M. D. Mashkovsky, Medical Substances vol. 2, p. 384, Hamta, Vilnius, (1993).
12. N. B. Graham, M. Zulfiqar, B. B. MacDonald and M. E. McNeill, J. Contr. Rel., 5, 244 (1988).